DOI:
10.1055/s-00029028
Journal of Pediatric Infectious Diseases
LinksClose Window
References
Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O.
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Pediatr Infect Dis J 2007;
26 (12) 1089-1093
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.